The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line treatment of iNHL or MCL patients with BR or R-CHOP/R-CVP: Results of the BRIGHT 5-year follow-up study.
 
Ian Flinn
No Relationships to Disclose
 
Richard van der Jagt
Consulting or Advisory Role - Lundbeck; Teva
Research Funding - Gilead Sciences; Novartis; Roche; Teva
 
Julie E. Chang
Research Funding - Celgene; Genentech
 
Peter Wood
Honoraria - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb
Consulting or Advisory Role - Bayer
 
Tim E. Hawkins
Travel, Accommodations, Expenses - Roche
 
David MacDonald
Honoraria - Amgen
Consulting or Advisory Role - Gilead Sciences; Janssen; Lundbeck; Roche; Seagen
 
Judith Trotman
No Relationships to Disclose
 
David Simpson
Honoraria - Celgene
Research Funding - Amgen
 
Kathryn S. Kolibaba
No Relationships to Disclose
 
Samar Issa
No Relationships to Disclose
 
Doreen M. Hallman
Employment - Teva
Stock and Other Ownership Interests - Teva
 
Ling Chen
Employment - Teva
Stock and Other Ownership Interests - Teva
 
John M. Burke
No Relationships to Disclose